Positive CLL Data For AstraZeneca's BTK Inhibitor Prompts Early ASCEND Trial End

 
• By Sten Stovall
Leukemia
Calquence is being developed for the treatment of multiple B-cell blood cancers including CLL. • Source: Shutterstock

More from Clinical Trials

More from R&D